Maria La Salette Hipólito Reis

Leader of the research group Molecular Biophysics and Biotechnology (MB2). The research activities include the development of “smart“ drug delivery systems for the treatment of tuberculosis, psoriasis and rheumatoid arthritis, among others. Additionally, the development of nanostructures loading bioactive compounds to be used as nutraceuticals represents an ongoing work. The research in these areas is based in a “quality by design” standpoint and include the synthesis, characterization and in vitro assessment of cytotoxicity, viability and efficacy of be developed nanosystems (SLN, NLC, liposomes, i.a.)